Tempero Bio, Inc., 2025-11-04
An SEC Form D private-offering notice from Oakland, CA, a $76,958,457 filer-stated offering target in Biotech. Filed 2025-11-04. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biopharmaceutical company developing TMP-301, an oral therapy for substance use disorders including alcohol and cocaine use disorder
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Lucendi, Inc., 2025-11-05, $1M, Los Angeles, CA
- Prelude Corp, 2025-11-06, $7.5M, Laguna Hills, CA
- Channel99, Inc., 2025-11-05, $2.5M, Kentfield, CA
- Luminary Therapeutics, Inc., 2025-11-05, $12.4M, Minneapolis, MN
- BAMO NV, Inc., 2025-11-04, $90, San Francisco, CA
- Osteal Therapeutics, Inc., 2025-11-05, $26.7M, Dallas, TX
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.